Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » The Scan » Quick Generation

Quick Generation

Feb 18, 2020

Using the genome sequence of the SARS-CoV-2 — previously dubbed 2019-nCoV — researchers can generate synthetic versions of the virus to study how the virus may spread or develop vaccines, though Technology Review notes that the research can raise concerns. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

German Shepherd's Own Sequence

A German shepherd called Nala has had her genome sequenced.

And Now Serology Tests

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Young at Brain

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

Science Paper Examines Factors to Identify Metastatic Prostate Cancer Responsive to Checkpoint Inhibitors

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

What's Popular?

In Infectious Disease

  1. With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

  2. Becton Dickinson, BioGX Get FDA Emergency Use Authorization for Rapid SARS-CoV-2 Test

  3. Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

  4. Siemens Healthineers Developing Molecular Kit for Coronavirus Detection

  5. LexaGene Shifts Gears to Prepare Viral RT-qPCR Panel for FDA Emergency Submission

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.